Claude Labrie - Related publications

Universite Laval (Canada) 
Molecular Biology, Oncology, Cell Biology
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Li Y, Li S, Zhang Y, Shi S, Qin S, Wang C, Du J, Ma J, Chen H, Cui H. Androgen Plays a Carcinogenic Role in EOC via the PI3K/AKT Signaling Pathway in an AR-Dependent Manner. Journal of Cancer. 12: 1815-1825. PMID 33613770 DOI: 10.7150/jca.51099   
2021 Hickey TE, Selth LA, Chia KM, Laven-Law G, Milioli HH, Roden D, Jindal S, Hui M, Finlay-Schultz J, Ebrahimie E, Birrell SN, Stelloo S, Iggo R, Alexandrou S, Caldon CE, et al. The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer. Nature Medicine. PMID 33462444 DOI: 10.1038/s41591-020-01168-7   
2021 Lei D, Hong T, Li L, Chen L, Luo X, Wu Q, Liu Z. Isobaric tags for relative and absolute quantitation-based proteomics analysis of the effect of ginger oil on bisphenol A-induced breast cancer cell proliferation. Oncology Letters. 21: 101. PMID 33376534 DOI: 10.3892/ol.2020.12362   
2021 Qin J, Qu S, Zhu K, Cheng Y, Pan G, Jing W, Liu X, Sun X, Liu L. Rational design and synthesis of 6-aryl-6H-benzo[c]chromenes as non-steroidal progesterone receptor antagonists for use against cancers. Bioorganic & Medicinal Chemistry. 32: 116003. PMID 33461148 DOI: 10.1016/j.bmc.2021.116003   
2021 Kim HA, Lee J. Hispidulin modulates epithelial-mesenchymal transition in breast cancer cells. Oncology Letters. 21: 155. PMID 33552273 DOI: 10.3892/ol.2020.12416   
2021 Thomas PB, Jeffery P, Gahete MD, Whiteside E, Walpole C, Maugham M, Jovanovic L, Gunter J, Williams E, Nelson C, Herington A, Luque RM, Veedu R, Chopin LK, Seim I. The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype. Peerj. 9: e10280. PMID 33585078 DOI: 10.7717/peerj.10280   
2021 Zhou J, Zhang S, Luo M. LncRNA promotes the malignant progression of breast cancer by regulating ErbB/PI3K/Akt pathway. Future Oncology (London, England). PMID 33401925 DOI: 10.2217/fon-2020-0273   
2021 Yang T, Wang P, Yin X, Zhang J, Huo M, Gao J, Li G, Teng X, Yu H, Huang W, Wang Y. The histone deacetylase inhibitor PCI-24781 impairs calcium influx and inhibits proliferation and metastasis in breast cancer. Theranostics. 11: 2058-2076. PMID 33500709 DOI: 10.7150/thno.48314   
2021 Jinka S, Rachamalla HK, Bhattacharyya T, Sridharan K, Sekhar Jaggarapu MMC, Yakati V, Banerjee R. Glucocorticoid receptor-targeted liposomal delivery system for delivering small molecule ESC8 and anti-miR-Hsp90 gene construct to combat colon cancer. Biomedical Materials (Bristol, England). PMID 33434900 DOI: 10.1088/1748-605X/abdb08   
2021 Wilson EA, Sultana N, Shah KN, Elford HL, Faridi JS. Molecular Targeting of RRM2, NF-κB, and Mutant TP53 for the Treatment of Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. PMID 33536192 DOI: 10.1158/1535-7163.MCT-20-0373   
2021 Wu Z, Ding Z, Cheng B, Cui Z. The inhibitory Effect of human DEFA5 in Growth of gastric cancer by targeting BMI-1. Cancer Science. PMID 33503272 DOI: 10.1111/cas.14827   
2021 Ayoub NM, Alkhalifa AE, Ibrahim DR, Alhusban A. Combined crizotinib and endocrine drugs inhibit proliferation, migration, and colony formation of breast cancer cells via downregulation of MET and estrogen receptor. Medical Oncology (Northwood, London, England). 38: 8. PMID 33449292 DOI: 10.1007/s12032-021-01458-1   
2021 Gao W, Wen H, Liang L, Dong X, Du R, Zhou W, Zhang X, Zhang C, Xiang R, Li N. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer. Theranostics. 11: 2564-2580. PMID 33456560 DOI: 10.7150/thno.45280   
2021 Shen W, Zhang X, Tang J, Zhang Z, Du R, Luo D, Liu X, Xia Y, Li Y, Wang S, Yan S, Yang W, Xiang R, Luo N, Luo Y, et al. CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis. Theranostics. 11: 2297-2317. PMID 33500726 DOI: 10.7150/thno.51000   
2021 Chen GY, Zhang ZS, Chen Y, Li Y. Long non-coding RNA SNHG9 inhibits ovarian cancer progression by sponging microRNA-214-5p. Oncology Letters. 21: 80. PMID 33363617 DOI: 10.3892/ol.2020.12341   
2021 Zhou L, Song Z, Hu J, Liu L, Hou Y, Zhang X, Yang X, Chen K. ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3. Theranostics. 11: 841-860. PMID 33391508 DOI: 10.7150/thno.49384   
2021 Sharma U, Barwal TS, Khandelwal A, Malhotra A, Rana MK, Singh Rana AP, Imyanitov EN, Vasquez KM, Jain A. LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3. Biochimie. PMID 33429003 DOI: 10.1016/j.biochi.2020.12.026   
2021 Li Y, Sun Y, Kulke M, Hechler T, Van der Jeught K, Dong T, He B, Miller KD, Radovich M, Schneider BP, Pahl A, Zhang X, Lu X. Targeted immunotherapy for HER2-low breast cancer with 17p loss. Science Translational Medicine. 13. PMID 33568521 DOI: 10.1126/scitranslmed.abc6894   
2021 Dey N, Aske J, De P. Targeted Neoadjuvant Therapies in HR+/HER2-Breast Cancers: Challenges for Improving pCR. Cancers. 13. PMID 33530335 DOI: 10.3390/cancers13030458   
2021 Lawal B, Liu YL, Mokgautsi N, Khedkar H, Sumitra MR, Wu ATH, Huang HS. Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines. Biomedicines. 9. PMID 33477856 DOI: 10.3390/biomedicines9010092   
2021 Lu AS, Rouhimoghadam M, Arnatt CK, Filardo EJ, Salem AK. Proteolytic Targeting Chimeras with Specificity for Plasma Membrane and Intracellular Estrogen Receptors. Molecular Pharmaceutics. PMID 33600191 DOI: 10.1021/acs.molpharmaceut.1c00018   
2021 Kumari S, Arora M, Singh J, Chauhan SS, Kumar S, Chopra A. L-Selectin expression is associated with inflammatory microenvironment and favourable prognosis in breast cancer. 3 Biotech. 11: 38. PMID 33479593 DOI: 10.1007/s13205-020-02549-y   
2021 Huang SB, Thapa D, Munoz AR, Hussain SS, Yang X, Bedolla RG, Osmulski P, Gaczynska ME, Lai Z, Chiu YC, Wang LJ, Chen Y, Rivas P, Shudde C, Reddick RL, et al. Androgen deprivation-induced elevated nuclear SIRT1 promotes prostate tumor cell survival by reactivation of AR signaling. Cancer Letters. PMID 33617947 DOI: 10.1016/j.canlet.2021.02.008   
2021 Nafie E, Lolarga J, Lam B, Guo J, Abdollahzadeh E, Rodriguez S, Glackin C, Liu J. Harmine inhibits breast cancer cell migration and invasion by inducing the degradation of Twist1. Plos One. 16: e0247652. PMID 33626096 DOI: 10.1371/journal.pone.0247652   
2021 Hu J, Zhang Y, Tang N, Lu Y, Guo P, Huang Z. Discovery of novel 1,3,5-triazine derivatives as potent inhibitor of cervical cancer via dual inhibition of PI3K/mTOR. Bioorganic & Medicinal Chemistry. 32: 115997. PMID 33440319 DOI: 10.1016/j.bmc.2021.115997   
2021 Hu J, Zhang Y, Tang N, Lu Y, Guo P, Huang Z. Discovery of novel 1,3,5-triazine derivatives as potent inhibitor of cervical cancer via dual inhibition of PI3K/mTOR. Bioorganic & Medicinal Chemistry. 32: 115997. PMID 33440319 DOI: 10.1016/j.bmc.2021.115997   
2021 Elgehama A, Sun L, Yu B, Guo W, Xu Q. Selective targeting of the androgen receptor-DNA binding domain by the novel antiandrogen SBF-1 and inhibition of the growth of prostate cancer cells. Investigational New Drugs. PMID 33411211 DOI: 10.1007/s10637-020-01050-w   
2021 Zhang N, Ji J, Zhou D, Liu X, Zhang X, Liu Y, Xiang W, Wang M, Zhang L, Wang G, Huang B, Lu J, Zhang Y. The Interaction of the Senescent and Adjacent Breast Cancer Cells Promotes the Metastasis of Heterogeneous Breast Cancer Cells through Notch Signaling. International Journal of Molecular Sciences. 22. PMID 33467780 DOI: 10.3390/ijms22020849   
2021 Junttila TT, Bravo-Perez D, Lo AA, Liang WC, Ziai J, Pham T, Ellerman D, Wu Y, Li J, Johnston J, Cai H, Ovacik M, Boswell CA, Mandikian D, Totpal K, et al. Anti-LYPD1/CD3 T cell dependent bispecific antibody for the treatment of ovarian cancer. Molecular Cancer Therapeutics. PMID 33536191 DOI: 10.1158/1535-7163.MCT-20-0490   
2021 Wan Q, Tang M, Sun SL, Hu J, Sun ZJ, Fang YT, He TC, Zhang Y. SNHG3 promotes migration, invasion, and epithelial-mesenchymal transition of breast cancer cells through the miR-186-5p/ZEB1 axis. American Journal of Translational Research. 13: 585-600. PMID 33594311   
2021 Singh S, Sutcliffe MD, Repich K, Atkins KA, Harvey JA, Janes KA. Pan-cancer Drivers are Recurrent Transcriptional Regulatory Heterogeneities in Early-stage Luminal Breast Cancer. Cancer Research. PMID 33531373 DOI: 10.1158/0008-5472.CAN-20-1034   
2021 Liu W, Wang L, Zhang J, Qiao L, Liu Y, Yang X, Zhang J, Zheng W, Ma Z. Purification of recombinant human chemokine CCL2 in and its function in ovarian cancer. 3 Biotech. 11: 8. PMID 33442507 DOI: 10.1007/s13205-020-02571-0   
2021 Ng ZL, Siew J, Li J, Ji G, Huang M, Liao X, Yu S, Chew Y, Png CW, Zhang Y, Wen S, Yang H, Zhou Y, Long YC, Jiang ZH, et al. PATZ1 (MAZR) Co-occupies Genomic Sites With p53 and Inhibits Liver Cancer Cell Proliferation via Regulating p27. Frontiers in Cell and Developmental Biology. 9: 586150. PMID 33598459 DOI: 10.3389/fcell.2021.586150   
2021 Ali DJ, He C, Xu H, Kumaravel S, Sun B, Zhou Y, Liu R, Xiao Z. Microvesicles mediate sorafenib resistance in liver cancer cells through attenuating p53 and enhancing FOXM1 expression. Life Sciences. 119149. PMID 33549596 DOI: 10.1016/j.lfs.2021.119149   
2021 Sleightholm R, Neilsen BK, Elkhatib S, Flores L, Dukkipati S, Zhao R, Choudhury S, Gardner B, Carmichael J, Smith L, Bennion N, Wahl A, Baine M. Percentage of Hormone Receptor Positivity in Breast Cancer Provides Prognostic Value: A Single-Institute Study. Journal of Clinical Medicine Research. 13: 9-19. PMID 33613796 DOI: 10.14740/jocmr4398   
2021 Go RE, Kim CW, Lee SM, Lee HK, Choi KC. Fenhexamid induces cancer growth and survival via estrogen receptor-dependent and PI3K-dependent pathways in breast cancer models. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. 112000. PMID 33484789 DOI: 10.1016/j.fct.2021.112000   
2021 Song JH, Park J, Park SL, Hwang B, Kim WJ, Lee C, Moon SK. A Novel Cyclic Pentadepsipeptide, -Methylsansalvamide, Suppresses Angiogenic Responses and Exhibits Antitumor Efficacy against Bladder Cancer. Cancers. 13. PMID 33430488 DOI: 10.3390/cancers13020191   
2021 Gordin M, Philip H, Zilberberg A, Gidoni M, Margalit R, Clouser C, Adams K, Vigneault F, Cohen IR, Yaari G, Efroni S. Breast cancer is marked by specific, Public T-cell receptor CDR3 regions shared by mice and humans. Plos Computational Biology. 17: e1008486. PMID 33465095 DOI: 10.1371/journal.pcbi.1008486   
2021 Miyauchi T, Takahashi M, Mitsuzuka K, Saiki Y, Okubo T, Vertino PM, Goto A, Arai Y, Horii A, Fukushige S. Aberrant Hypermethylation-Mediated Suppression of PYCARD Is Extremely Frequent in Prostate Cancer with Gleason Score ≥ 7. Disease Markers. 2021: 8858905. PMID 33628338 DOI: 10.1155/2021/8858905   
2021 Humayun M, Ayuso JM, Brenneke RA, Virumbrales-Muñoz M, Lugo-Cintrón K, Kerr S, Ponik SM, Beebe DJ. Elucidating cancer-vascular paracrine signaling using a human organotypic breast cancer cell extravasation model. Biomaterials. 270: 120640. PMID 33592387 DOI: 10.1016/j.biomaterials.2020.120640   
2021 Stoletov K, Willetts L, Beatty PH, Lewis JD. Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model. Journal of Visualized Experiments : Jove. PMID 33616096 DOI: 10.3791/62077   
2021 Kuehn J, Espinoza-Sanchez NA, Teixeira FCOB, Pavão MSG, Kiesel L, Győrffy B, Greve B, Götte M. Prognostic significance of hedgehog signaling network-related gene expression in breast cancer patients. Journal of Cellular Biochemistry. PMID 33417295 DOI: 10.1002/jcb.29886   
2021 Xu J, Ou X, Li J, Cai Q, Sun K, Ye J, Peng J. Overexpression of TC2N is associated with poor prognosis in gastric cancer. Journal of Cancer. 12: 807-817. PMID 33403038 DOI: 10.7150/jca.50653   
2021 Centenera MM, Scott JS, Machiels J, Nassar ZD, Miller DC, Zininos I, Dehairs J, Burvenich IJG, Zadra G, Chetta P, Bango C, Evergren E, Ryan NK, Gillis JL, Mah CY, et al. ELOVL5 is a critical and targetable fatty acid elongase in prostate cancer. Cancer Research. PMID 33547161 DOI: 10.1158/0008-5472.CAN-20-2511   
2021 Kamata T, Yang CS, Melhuish TA, Frierson HF, Wotton D, Paschal BM. Post-Transcriptional Regulation of PARP7 Protein Stability Is Controlled by Androgen Signaling. Cells. 10. PMID 33572475 DOI: 10.3390/cells10020363   
2021 Gui C, Zhang C, Xiong X, Huang J, Xi J, Gong L, Huang B, Zhang X. Total flavone extract from Ampelopsis megalophylla induces apoptosis in the MCF‑7 cell line. International Journal of Oncology. PMID 33469684 DOI: 10.3892/ijo.2021.5172   
2021 Kim DH, Yong HJ, Mander S, Nguyen HT, Nguyen LP, Park HK, Cha HK, Kim WK, Hwang JI. SP-8356, a (1S)-(-)-Verbenone Derivative, Inhibits the Growth and Motility of Liver Cancer Cells by Regulating NF-κB and ERK Signaling. Biomolecules & Therapeutics. PMID 33455945 DOI: 10.4062/biomolther.2020.200   
2021 Chan PF, Ang KP, Hamid RA. A bismuth diethyldithiocarbamate compound induced apoptosis via mitochondria-dependent pathway and suppressed invasion in MCF-7 breast cancer cells. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. PMID 33555494 DOI: 10.1007/s10534-021-00286-0   
2021 Amoroso F, Glass K, Singh R, Liberal F, Steele RE, Maguire S, Tarapore R, Allen JE, Van Schaeybroeck S, Butterworth KT, Prise K, O'Sullivan JM, Jain S, Waugh DJ, Mills IG. Modulating the unfolded protein response with ONC201 to impact on radiation response in prostate cancer cells. Scientific Reports. 11: 4252. PMID 33608585 DOI: 10.1038/s41598-021-83215-y   
2021 An CX, Xie SP, Li HL, Hu YH, Niu R, Zhang LJ, Jiang Y, Li Q, Zhou YN. Knockdown of Microtubule Associated Serine/threonine Kinase Like Expression Inhibits Gastric Cancer Cell Growth and Induces Apoptosis by Activation of ERK1/2 and Inactivation of NF-κB Signaling. Current Medical Science. 41: 108-117. PMID 33582914 DOI: 10.1007/s11596-021-2325-2